Ilex Capital Partners’s Colgate-Palmolive CL Stock Holding History

Ilex Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.2M	Buy	+591,563	New	+$51.8M	1.11%	32
2026 Q1	–	Sell	-2,087,190	Closed	-$165M	–	79
2025 Q4	$165M	Buy	+2,087,190	New	+$164M	4.65%	5
2025 Q3	–	Sell	-686,136	Closed	-$62.4M	–	149
2025 Q2	$62.4M	Buy	+686,136	New	+$62.6M	2.06%	15
2025 Q1	–	Sell	-689,065	Closed	-$62.6M	–	192
2024 Q4	$62.6M	Buy	+689,065	New	+$65.8M	4.01%	8
2024 Q3	–	Sell	-473,410	Closed	-$45.9M	–	26
2024 Q2	$45.9M	Buy	+473,410	New	+$43.7M	4.71%	11
2024 Q1	–	Sell	-1,488,356	Closed	-$119M	–	21
2023 Q4	$119M	Buy	+1,488,356	New	+$112M	16.57%	1

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ilex Capital Partners's CL Position: Q2 2026 in Review

Ilex Capital Partners opened a new position in Colgate-Palmolive (CL) in Q2 2026: 591,563 shares worth $54.2M. The stake represents 1.11% of the portfolio and ranks #32 among its holdings. This is a return to the name: Ilex Capital Partners previously reported a position in CL as recently as Q4 2025.

Ilex Capital Partners first reported a position in CL in Q4 2023 and has held it in 6 quarters since. The position peaked at $165M in Q4 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Ilex Capital Partners held 591,563 shares of Colgate-Palmolive worth $54.2M as of Q2 2026.
Colgate-Palmolive was a new Ilex Capital Partners position in Q2 2026.
Colgate-Palmolive made up 1.11% of Ilex Capital Partners's portfolio in Q2 2026, its #32 holding.
Ilex Capital Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 6 quarters since.
Ilex Capital Partners's Colgate-Palmolive position peaked at $165M in Q4 2025.
2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.